• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用动态对比增强磁共振成像鉴别前列腺癌与正常外周带及中央腺体组织。

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.

作者信息

Engelbrecht Marc R, Huisman Henkjan J, Laheij Robert J F, Jager Gerrit J, van Leenders Geert J L H, Hulsbergen-Van De Kaa Christina A, de la Rosette Jean J M C H, Blickman Johan G, Barentsz Jelle O

机构信息

Department of Radiology, University Medical Center Nijmegen, PO Box 9101, NL 6500 HB Nijmegen, the Netherlands.

出版信息

Radiology. 2003 Oct;229(1):248-54. doi: 10.1148/radiol.2291020200. Epub 2003 Aug 27.

DOI:10.1148/radiol.2291020200
PMID:12944607
Abstract

PURPOSE

To evaluate which parameters of dynamic magnetic resonance (MR) imaging and T2 relaxation rate would result in optimal discrimination of prostatic carcinoma from normal peripheral zone (PZ) and central gland (CG) tissues and to correlate these parameters with tumor stage, Gleason score, patient age, and tumor markers.

MATERIALS AND METHODS

Of 58 patients with prostatic carcinoma, 36 were included for analysis. Patients underwent MR imaging at 1.5 T with an endorectal-pelvic phased-array coil and subsequently underwent prostatectomy. A T2-weighted turbo spin-echo sequence, an intermediate-weighted sequence, and a fast T1-weighted gradient-echo sequence (seven sections in 2.03 seconds) during bolus injection of 0.1 mmol gadopentetate dimeglumine per kilogram of body weight were performed. Contrast agent concentration-time curves were obtained for prostatic carcinoma and normal PZ and CG tissue by using whole-mount sections to guide placement of regions of interest. Onset time, time to peak, peak enhancement, relative peak enhancement, washout, and T2 relaxation rates were calculated. Multivariate receiver operating characteristic analysis was performed with and without relative peak enhancement.

RESULTS

Results of multivariate receiver operating characteristic analysis showed that relative peak enhancement demonstrated the highest area under the receiver operating characteristic curve (AUC) in the PZ and the CG (AUC = 0.93, 0.82). Results of multivariate analysis without relative peak enhancement showed that relative peak enhancement in the PZ and washout in the CG demonstrated the highest AUC (AUC = 0.9, 0.81). Pearson correlation coefficients between the dynamic parameters or T2 relaxation rates in carcinoma and the tumor stage, Gleason score, patient age, and tumor markers ranged between 0.02 and 0.44.

CONCLUSION

The optimal parameter for discrimination of prostatic carcinoma in the PZ and CG was relative peak enhancement. If relative peak enhancement was not used, then peak enhancement was optimal in the PZ, and washout was optimal in the CG. Poor-to-moderate correlation was present between the dynamic parameters or T2 relaxation rate in carcinoma and the tumor stage, Gleason score, patient age, tumor volume, and prostate-specific antigen.

摘要

目的

评估动态磁共振(MR)成像和T2弛豫率的哪些参数能实现前列腺癌与正常外周带(PZ)和中央腺体(CG)组织的最佳鉴别,并将这些参数与肿瘤分期、Gleason评分、患者年龄和肿瘤标志物相关联。

材料与方法

58例前列腺癌患者中,36例纳入分析。患者采用直肠内盆腔相控阵线圈在1.5T下行MR成像,随后接受前列腺切除术。在静脉团注每千克体重0.1mmol钆喷酸葡胺期间,行T2加权快速自旋回波序列、中等加权序列和快速T1加权梯度回波序列(2.03秒内采集7层)。通过全层切片指导感兴趣区的放置,获得前列腺癌及正常PZ和CG组织的对比剂浓度-时间曲线。计算起始时间、达峰时间、峰值强化、相对峰值强化、廓清率和T2弛豫率。进行有和没有相对峰值强化的多变量受试者操作特征分析。

结果

多变量受试者操作特征分析结果显示,相对峰值强化在PZ和CG中的受试者操作特征曲线下面积(AUC)最高(AUC = 0.93,0.82)。没有相对峰值强化的多变量分析结果显示,PZ中的相对峰值强化和CG中的廓清率的AUC最高(AUC = 0.9,0.81)。癌组织中的动态参数或T2弛豫率与肿瘤分期、Gleason评分、患者年龄和肿瘤标志物之间的Pearson相关系数在0.02至0.44之间。

结论

鉴别PZ和CG中前列腺癌的最佳参数是相对峰值强化。如果不使用相对峰值强化,则PZ中的峰值强化最佳,CG中的廓清率最佳。癌组织中的动态参数或T2弛豫率与肿瘤分期、Gleason评分、患者年龄、肿瘤体积和前列腺特异性抗原之间存在弱至中度的相关性。

相似文献

1
Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.利用动态对比增强磁共振成像鉴别前列腺癌与正常外周带及中央腺体组织。
Radiology. 2003 Oct;229(1):248-54. doi: 10.1148/radiol.2291020200. Epub 2003 Aug 27.
2
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.3T磁共振成像动态对比增强扫描在前列腺癌中的应用:药代动力学参数研究
AJR Am J Roentgenol. 2007 Oct;189(4):849. doi: 10.2214/AJR.06.1329.
3
Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.前列腺动态对比增强磁共振成像分析:快速交换极限与快速交换方案药代动力学模型在鉴别恶性组织与正常组织中的比较
Invest Radiol. 2009 Sep;44(9):577-84. doi: 10.1097/RLI.0b013e3181b4c1fe.
4
MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.MRI 检测前列腺癌:联合表观扩散系数、代谢物比值和血管参数。
AJR Am J Roentgenol. 2009 Dec;193(6):1583-91. doi: 10.2214/AJR.09.2540.
5
Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.动态对比增强 MRI 检测前列腺癌:计算机辅助诊断与单一时相灌注参数图比较。
AJR Am J Roentgenol. 2011 Nov;197(5):1122-9. doi: 10.2214/AJR.10.6062.
6
Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging.利用动态对比增强磁共振成像和质子磁共振波谱成像进行前列腺癌定位
Radiology. 2006 Nov;241(2):449-58. doi: 10.1148/radiol.2412051866. Epub 2006 Sep 11.
7
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.前列腺癌的动态对比增强磁共振成像:与形态学、肿瘤分期、组织学分级及前列腺特异抗原的相关性
Clin Radiol. 2000 Feb;55(2):99-109. doi: 10.1053/crad.1999.0327.
8
Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging.钆增强直肠内线圈磁共振成像对前列腺及前列腺癌的评估
Radiology. 1993 Jan;186(1):153-7. doi: 10.1148/radiology.186.1.8416557.
9
Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.多参数磁共振成像检测前列腺癌:定量T2、扩散加权成像和动态对比增强磁共振成像的逻辑回归分析
J Magn Reson Imaging. 2009 Aug;30(2):327-34. doi: 10.1002/jmri.21824.
10
Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.使用动态对比增强反转准备双对比梯度回波序列通过定量灌注分析评估正常前列腺组织、慢性前列腺炎和前列腺癌。
Invest Radiol. 2008 Jul;43(7):481-7. doi: 10.1097/RLI.0b013e31816b2f63.

引用本文的文献

1
Classification of liver lesions based on temporal changes in hepatobiliary phase contrast on magnetic resonance imaging: a preliminary study.基于磁共振成像肝胆期对比剂时间变化的肝脏病变分类:一项初步研究。
Radiol Phys Technol. 2025 Sep 5. doi: 10.1007/s12194-025-00933-y.
2
A deep learning derived prostate zonal volume-based biomarker from T2-weighted MRI to distinguish between prostate cancer and benign prostatic hyperplasia.一种基于深度学习从T2加权磁共振成像得出的前列腺带区体积生物标志物,用于区分前列腺癌和良性前列腺增生。
Med Phys. 2025 Aug;52(8):e18053. doi: 10.1002/mp.18053.
3
Quantitative DCE Dynamics on Transformed MR Imaging Discriminates Clinically Significant Prostate Cancer.
转化型磁共振成像定量 DCE 动力学可区分临床显著前列腺癌。
Cancer Control. 2024 Jan-Dec;31:10732748241298539. doi: 10.1177/10732748241298539.
4
Enhancing the diagnostic capacity of [F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study.利用人工智能和半定量动态对比增强磁共振成像提高[F]PSMA-1007正电子发射断层扫描/磁共振成像在原发性前列腺癌分期中的诊断能力:一项探索性研究。
EJNMMI Rep. 2024 Nov 8;8(1):37. doi: 10.1186/s41824-024-00225-5.
5
Development and validation of a nomogram incorporating multi-parametric MRI and hematological indicators for discriminating benign from malignant central prostatic nodules: a retrospective analysis.一种结合多参数MRI和血液学指标以鉴别前列腺中央结节良恶性的列线图的开发与验证:一项回顾性分析
Am J Transl Res. 2024 Jul 15;16(7):2921-2930. doi: 10.62347/RBCM8913. eCollection 2024.
6
Optimal length and temporal resolution of dynamic contrast-enhanced MR imaging for the differentiation between prostate cancer and normal peripheral zone tissue.动态对比增强磁共振成像的最佳长度和时间分辨率在前列腺癌与正常外周带组织鉴别中的作用。
PLoS One. 2023 Jun 23;18(6):e0287651. doi: 10.1371/journal.pone.0287651. eCollection 2023.
7
Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.比较在初诊男性中用双参数 MRI 与多参数 MRI 诊断临床显著前列腺癌(PRIME):一项前瞻性、国际、多中心、患者内非劣效性、诊断效能试验方案。
BMJ Open. 2023 Apr 5;13(4):e070280. doi: 10.1136/bmjopen-2022-070280.
8
Effects of dynamic contrast enhancement on transition zone prostate cancer in Prostate Imaging Reporting and Data System Version 2.1.动态对比增强对前列腺成像报告和数据系统第 2.1 版移行区前列腺癌的影响。
Radiol Oncol. 2023 Jan 20;57(1):42-50. doi: 10.2478/raon-2023-0007. eCollection 2023 Mar 1.
9
Role of MRI-US Fusion Biopsy in Diagnosing Prostatic Cancer.MRI-超声融合活检在前列腺癌诊断中的作用
Indian J Surg Oncol. 2017 Sep;8(3):357-360. doi: 10.1007/s13193-016-0612-3. Epub 2017 Mar 2.
10
Assessment of Early Response to Lung Cancer Chemotherapy by Semiquantitative Analysis of Dynamic Contrast-Enhanced MRI.动态对比增强 MRI 半定量分析评估肺癌化疗的早期反应。
Dis Markers. 2022 Jul 23;2022:2669281. doi: 10.1155/2022/2669281. eCollection 2022.